Withdrawal of Approval of Drug Application: Secura Bio, Inc.; Farydak (Panobinostat) Capsules, 10 Milligrams, 15 Milligrams, and 20 Milligrams

TitleWithdrawal of Approval of Drug Application: Secura Bio, Inc.; Farydak (Panobinostat) Capsules, 10 Milligrams, 15 Milligrams, and 20 Milligrams
ToC Doc Secura Bio, Inc.; Farydak (Panobinostat) Capsules, 10 Milligrams, 15 Milligrams, and 20 Milligrams
Docket Number2022-06182
Type Notice
Subject Withdrawal of Approval of Drug Application:
Secura Bio, Inc.; Farydak (Panobinostat) Capsules, 10 Milligrams, 15 Milligrams, and 20 Milligrams
Publication Date2022-03-24
Last Updated Date 2022-03-23 08:15:08 -0400
Last Public Inspection2022-03-23
Filed At2022-03-23T08:45:00.000-04:00
PDF 2022-06182_PI.pdf (91360 bytes)
Download TXT / HTML / JSON
Number of Pages 3
Filing Typeregular
AgenciesFood and Drug Administration

You can find the raw source document below...

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. OFR.report is not affiliated with the Office of the Federal Register or the US government in any way.

© OFR.report 2021